The COVID-19 Infectious Disease team at University Health System andUT Health San Antonio has launched the second stage of a clinical trial involving a coronavirus drug that has delivered promising results.
Thomas Patterson, M.D., a professor in the Long School of Medicine and chief of the Division of Infectious Diseases at UT Health San Antonio, is leading the study at University Hospital.